[go: up one dir, main page]

DK0610078T3 - Cytotoksisk og antiviral forbindelse. - Google Patents

Cytotoksisk og antiviral forbindelse.

Info

Publication number
DK0610078T3
DK0610078T3 DK94300780.7T DK94300780T DK0610078T3 DK 0610078 T3 DK0610078 T3 DK 0610078T3 DK 94300780 T DK94300780 T DK 94300780T DK 0610078 T3 DK0610078 T3 DK 0610078T3
Authority
DK
Denmark
Prior art keywords
cytotoxic
antiviral compound
compound
kalahide
sacoglossan
Prior art date
Application number
DK94300780.7T
Other languages
English (en)
Inventor
Paul J Schauer
Dolores G Gravalos
Mark T Hamann
Original Assignee
Pharma Mar Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Mar Sa filed Critical Pharma Mar Sa
Application granted granted Critical
Publication of DK0610078T3 publication Critical patent/DK0610078T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK94300780.7T 1993-02-03 1994-02-02 Cytotoksisk og antiviral forbindelse. DK0610078T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939302046A GB9302046D0 (en) 1993-02-03 1993-02-03 Antiumoral compound-v

Publications (1)

Publication Number Publication Date
DK0610078T3 true DK0610078T3 (da) 1997-10-20

Family

ID=10729727

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94300780.7T DK0610078T3 (da) 1993-02-03 1994-02-02 Cytotoksisk og antiviral forbindelse.

Country Status (11)

Country Link
EP (1) EP0610078B1 (da)
JP (1) JP3452628B2 (da)
AT (1) ATE151776T1 (da)
AU (1) AU677258B2 (da)
CA (1) CA2114859C (da)
DE (1) DE69402576T2 (da)
DK (1) DK0610078T3 (da)
ES (1) ES2102772T3 (da)
GB (1) GB9302046D0 (da)
GR (1) GR3024028T3 (da)
ZA (1) ZA94748B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0002952D0 (en) * 2000-02-09 2000-03-29 Pharma Mar Sa Process for producing kahalalide F compounds
BR0114912A (pt) * 2000-10-31 2003-10-14 Pharma Mar Sa Kahalalide f
AU2002334203C1 (en) * 2001-10-19 2008-10-09 Pharma Mar, S.A. Kahalalide compounds for use in cancer therapy
GB0304367D0 (en) * 2003-02-26 2003-04-02 Pharma Mar Sau Methods for treating psoriasis
ATE490975T1 (de) * 2002-10-18 2010-12-15 Pharma Mar Sau 4-methylhexanoic kahalalide f verbindung
MXPA05004133A (es) * 2002-10-18 2005-10-05 Pharma Mar Sau Nuevos compuestos antitumorales.
US7507708B2 (en) 2003-02-26 2009-03-24 Pharma Mar, S.A.U. Antitumoral compounds
GB0321066D0 (en) 2003-09-09 2003-10-08 Pharma Mar Sau New antitumoral compounds
MX2010004259A (es) * 2007-10-19 2010-08-31 Pharma Mar Sa Tratamientos antitumorales mejorados.
JP2011513370A (ja) * 2008-03-07 2011-04-28 ファルマ・マール・ソシエダード・アノニマ 改善された抗腫瘍治療法
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2054011T3 (es) * 1988-09-05 1994-08-01 Sankyo Co Un proceso para la preparacion de un compuesto, "leualacina".
US4986988A (en) * 1989-05-18 1991-01-22 Arizona Board Of Regents Isolation and structural elucidation of the cytostatic linear depsipeptides dolastatin 13 and dehydrodolastatin 13

Also Published As

Publication number Publication date
EP0610078B1 (en) 1997-04-16
GR3024028T3 (en) 1997-10-31
EP0610078A1 (en) 1994-08-10
CA2114859C (en) 2008-04-15
ZA94748B (en) 1994-09-29
GB9302046D0 (en) 1993-03-24
ES2102772T3 (es) 1997-08-01
JP3452628B2 (ja) 2003-09-29
AU5491194A (en) 1994-08-11
DE69402576T2 (de) 1997-10-02
CA2114859A1 (en) 1994-08-04
JPH0770185A (ja) 1995-03-14
DE69402576D1 (de) 1997-05-22
ATE151776T1 (de) 1997-05-15
AU677258B2 (en) 1997-04-17

Similar Documents

Publication Publication Date Title
IL94915A (en) Substituted quinazolinones and pharmaceutical compositions containing them
ATE269290T1 (de) Benzoylderivate
TW226375B (da)
FI905983A0 (fi) Aminosyraderivat.
DE69426904D1 (de) Phosphonat-Nukleotid Ester-Derivate
HU9402342D0 (en) Phosphono-oxymethyl-ethers of taxane derivatives
DK0671933T3 (da) Hidtil ukendte anvendelser af IL-10
ES2051641A1 (es) Procedimientos para la preparacion de compuestos derivados de tiourea.
FI920023A0 (fi) Heteroarylpiperazinfoereningar som antipsykotiska aemnen.
IL94484A0 (en) Diarylstyrylquinoline diacids and pharmaceutical compositions containing them
GR1000118B (el) Συνθεσις 1,2-διοξετανων & ενδιαμεσαι ουσιαι δι αυτην.
TW280813B (da)
IL87421A (en) Pharmaceutical compositions containing 5-amino (or substituted amino) - 1,2,3-triazoles
DK0610078T3 (da) Cytotoksisk og antiviral forbindelse.
FI960658A (fi) Uudet bis-naftalimidit syövän hoitamiseksi
DK0613687T3 (da) Anvendelse af pregnanderivat til behandling af tumorer
DK638787A (da) Anthracyclinderivater, deres fremstilling og anvendelse
DK0418990T3 (da) 13-brom- og 13,14-dibrom-ergoliner, deres fremstilling og anvendelse i lægemidler
DK656889A (da) Azabicykliske derivater
ES2053808T3 (es) Nuevos compuestos azolicos.
EP0412941A3 (en) Phospholipids for the treatment of multiple sclerosis
IT1262952B (it) Tetraalchilpiperidine, loro preparazione e loro impiego come stabilizzanti alla luce. (caso 153-5502)